Liminal BioSciences

📍 Laval, Canada👥 34 employees💰 Last funded Dec 2018
Biotechnology Research🌐 liminalbiosciences.com
Website LinkedIn
Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G protein-coupled receptor (GPCR) pathways. The company is developing new proprietary small molecule therapeutic candidates with the intention of developing best-in-class therapeutics for the treatment of unmet metabolic, inflammatory and fibrotic diseases, using its integrated drug discovery platform, expertise in medicinal chemistry and deep understanding of GPCR biology. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. See our social media community guidelines at https://liminalbiosciences.com/social-media-community-guidelines/
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Liminal BioSciences?
Liminal BioSciences has 1 investors on record on gritt.io.
When did Liminal BioSciences last raise funding?
The most recent investment in Liminal BioSciences recorded on gritt.io was in December 2018.
What industry is Liminal BioSciences in?
Liminal BioSciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Liminal BioSciences based?
Liminal BioSciences is headquartered in Laval, Canada.